Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome® or Fungizone™

Open Access

Peer-reviewed

Research Article

Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome^® or Fungizone™

Jagdishbhai L. Italia,

Affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
⨯
Andrew Sharp,

Affiliation School of Translational Medicine, The University of Manchester, Manchester, United Kingdom
⨯
Katharine C. Carter,

Affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
⨯
Peter Warn ,

* E-mail: peter.warn@manchester.ac.uk (PW); mnvrkumar@strath.ac.uk (MNVRK)

Affiliation School of Translational Medicine, The University of Manchester, Manchester, United Kingdom
⨯
M. N. V. Ravi Kumar

* E-mail: peter.warn@manchester.ac.uk (PW); mnvrkumar@strath.ac.uk (MNVRK)

Affiliation Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom
⨯

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Aspergillosis
Is the Subject Area "Aspergillosis" applicable to this article?

Thanks for your feedback.
Ethanol
Is the Subject Area "Ethanol" applicable to this article?

Thanks for your feedback.
Polymers
Is the Subject Area "Polymers" applicable to this article?

Thanks for your feedback.
Nanoparticles
Is the Subject Area "Nanoparticles" applicable to this article?

Thanks for your feedback.
Oral administration
Is the Subject Area "Oral administration" applicable to this article?

Thanks for your feedback.
Intravenous injections
Is the Subject Area "Intravenous injections" applicable to this article?

Thanks for your feedback.
Kidneys
Is the Subject Area "Kidneys" applicable to this article?

Thanks for your feedback.